This is the authors' abstract. We don't add key points for this paper.
A monoanionic phosphoramide ligand is introduced, which forms a series of lanthanum complexes with the ligand in both anionic and neutral forms. Stoichiometric control alone provides monometallic complexes with either two or three phosphoramide ligands. Alternatively, a combination of anionic and neutral proteo ligands featuring intramolecular hydrogen bonding can be obtained. The anionic form of the ligand binds lanthanum as a bi- or monodentate ligand, depending on the steric demand at the metal center, while the protonated ligand binds exclusively through the phosphoramide oxygen donor.
No takes yet. Share an insight, caveat, or question.
Boggiano et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: